MICRO+6 REGULAR 12 MCG
SELENIUM (SELENIUM DIOXIDE) : 12 MCG COPPER (CUPRIC SULFATE) : 60 MCG CHROMIUM (CHROMIC CHLORIDE) : 2 MCG ZINC (ZINC SULFATE) : 1 MG IODINE (SODIUM IODIDE) : 15 MCG MANGANESE (MANGANESE SULFATE) : 11 MCG · DIN 02552787 · SANDOZ CANADA INCORPORATED
Health Canada status: MARKETED
What is MICRO+6 REGULAR?
MICRO+6 REGULAR 12 MCG contains SELENIUM (SELENIUM DIOXIDE) : 12 MCG COPPER (CUPRIC SULFATE) : 60 MCG CHROMIUM (CHROMIC CHLORIDE) : 2 MCG ZINC (ZINC SULFATE) : 1 MG IODINE (SODIUM IODIDE) : 15 MCG MANGANESE (MANGANESE SULFATE) : 11 MCG. It is listed in the Health Canada Drug Product Database under DIN 02552787, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 30-May-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MICRO+6 REGULAR used for?
Supplement to intravenous solutions given for TPN to maintain plasma zinc, copper, manganese, chromium, selenium, and iodide levels and prevent deficiency symptoms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02552787 |
|---|---|
| Brand name | MICRO+6 REGULAR |
| Generic / active ingredient | SELENIUM (SELENIUM DIOXIDE) : 12 MCG COPPER (CUPRIC SULFATE) : 60 MCG CHROMIUM (CHROMIC CHLORIDE) : 2 MCG ZINC (ZINC SULFATE) : 1 MG IODINE (SODIUM IODIDE) : 15 MCG MANGANESE (MANGANESE SULFATE) : 11 MCG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 12 MCG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 30-May-2025 |
How is it administered?
Aseptic addition to TPN solution (amino acid or dextrose). Must be diluted before use. Use within 24 hours (room temp) or 48 hours (refrigerated). Single use vial.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
After dilution, use within 24 hours or 48 hours if refrigerated (5 ± 3ºC). (Note: specific unopened storage temp not provided in text snippet).
How is it supplied?
Available in single use vials of 5 mL, boxes of 10. Stopper is not made with natural rubber latex.
Contraindications
Hypersensitivity to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
Warnings and precautions
Hypotonic solution; must be diluted. Do not give by direct injection (risk of phlebitis). Manganese/copper retention in biliary obstruction. Zinc/selenium/iodine retention in renal dysfunction.
What can be used instead?
Other Canadian products sharing ATC code B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS. 5 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ADDNUTRIV | 380 MCG / 10 ML | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02497697 |
| MICRO +4 REGULAR STRENGTH | 1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02091135 |
| MICRO+ TE PEDIATRIC | 20 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02536145 |
| MICRO+6 CONCENTRATE | 5 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02507587 |
| MICRO PLUS 4 CONCENTRATE | 1 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091143 |
| MICRO PLUS 5 CONCENTRATE | 0.5 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091178 |
| MICRO PLUS 6 (CONCENTRATE) | 0.5 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091127 |
| MICRO PLUS 6 (PEDIATRIC) | 4 MCG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091100 |
| MICRO PLUS 6 (REGULAR) | 0.4 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02091119 |
| SELEPEN INJ 40MCG/ML USP | 40 MCG | LIQUID | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | CANCELLED POST MARKET | DIN 01945335 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.